Council Focused On Japanese Regs For Quasi-Drugs, Anti-Aging Included
This article was originally published in The Rose Sheet
Executive Summary
Japan's Ministry of Health, Labor and Welfare vows to keep up discussions with stakeholders - including U.S. industry - on "ways to increase the transparency and efficiency" of its approval process for quasi-drugs, which include anti-aging products
You may also be interested in...
Policy Panel: Council Execs Highlight Regulatory Priorities At Home & Abroad
The Personal Care Products Council welcomes FDA's reenergized science focus by expanding its Cosmetic Ingredient Review program, with plans to review almost 50 percent more substances this year than last
Policy Panel: Council Execs Highlight Regulatory Priorities At Home & Abroad
The Personal Care Products Council welcomes FDA's reenergized science focus by expanding its Cosmetic Ingredient Review program, with plans to review almost 50 percent more substances this year than last
ICCR Addresses Cosmetic Labeling, Nanotechnology At First Meeting
The International Cooperation on Cosmetics Regulation invites the cosmetics industry to generate and submit data showing that U.S. consumers understand the meaning of "trivial names" on product labeling